PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 2 months ago Inside Information / Other news releases Sensorion announces participation in ARO 48th Annual Midwinter Meeting with focus on gene therapy for deafness. Details of presentations by Sensorion executives included Gene Therapy Sensorion ARO Meeting Deafness Sensorion Executives
PRESS RELEASE published on 02/12/2025 at 11:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Sensorion participe à la 48ème rencontre annuelle de l'ARO pour présenter ses thérapies novatrices contre la perte auditive Sensorion Perte Auditive Thérapies ARO Rencontre Annuelle
BRIEF published on 12/27/2024 at 07:35, 1 year 4 months ago Sensorion Completes Enrollment for Audiogene Phase 1/2 Trial Gene Therapy Sensorion Hearing Loss SENS-501 Audiogene Trial
BRIEF published on 12/27/2024 at 07:35, 1 year 4 months ago Sensorion finalise le recrutement pour l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion Perte Auditive SENS-501 Essai Audiogene
PRESS RELEASE published on 12/27/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion completes enrollment of the first cohort in the Audiogene Phase 1/2 gene therapy clinical trial, targeting infants with hearing loss disorders Gene Therapy Clinical Trial Sensorion Hearing Loss Disorders Audiogene
BRIEF published on 12/18/2024 at 07:35, 1 year 4 months ago Sensorion présente des résultats préliminaires positifs pour le SENS-501 Essai Clinique Thérapie Génique Innovation Biotechnologique SENS-501 Surdité Congénitale
BRIEF published on 12/18/2024 at 07:35, 1 year 4 months ago Sensorion Reports Positive Preliminary Results for SENS-501 Gene Therapy Clinical Trial SENS-501 Congenital Deafness Biotechnological Innovation
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion présente des données positives de l'essai clinique de Phase 1/2 de thérapie génique pour la surdité chez les nourrissons. Nouvelles données encourageantes sur SENS-501. Séminaire en ligne prévu pour 2025 Sécurité Thérapie Génique Phase 1/2 Sensorion Surdité
PRESS RELEASE published on 12/18/2024 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion reports positive safety data and behavioral changes in toddlers from the Audiogene Phase 1/2 Gene Therapy Clinical Trial. Plans KOL event in 2025 for further discussion Gene Therapy Clinical Trial Sensorion Hearing Loss Audiogene
BRIEF published on 11/06/2024 at 07:35, 1 year 5 months ago Sensorion to Join Key Investor Conferences in November 2024 Biotechnology Investor Conferences Sensorion Hearing Loss Therapies Gene Therapy Development
Published on 05/04/2026 at 22:15, 30 minutes ago Battery X Metals Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
Published on 05/04/2026 at 22:05, 40 minutes ago Unusual Machines to Announce First Quarter 2026 Financial Results and Provide Corporate Update
Published on 05/04/2026 at 20:45, 2 hours ago Silver Spruce Resources Inc. Announces Change to Director Slate for Annual General and Special Meeting of Shareholders
Published on 05/04/2026 at 16:27, 6 hours 18 minutes ago Avenir Minerals to Acquire Fox River Resources in All-Cash Transaction for Approximately C$94.3 Million
Published on 05/04/2026 at 21:05, 1 hour 40 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for Q1 2026 of €47.9 million and adjusted EBITDA of €7.6 million; forecast for the continuing operations unchanged
Published on 05/04/2026 at 20:02, 2 hours 42 minutes ago EQS-Adhoc: Rheinmetall AG: Preliminary operating margin in line with market expectation; revenue below market expectation despite growth due to delays into Q2 – 2026 full-year forecast reaffirmed
Published on 05/04/2026 at 19:30, 3 hours 15 minutes ago Shareholders approve all proposals – Dr Annelise Lüscher Hämmerli and Urs Simeon elected to the Board of Directors
Published on 05/04/2026 at 19:00, 3 hours 45 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 27 AVRIL 2026 au 01 MAI 2026
Published on 05/04/2026 at 19:00, 3 hours 45 minutes ago L’Assemblée générale 2026 approuve toutes les propositions du Conseil d’administration
Published on 05/04/2026 at 20:57, 1 hour 48 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 05/04/2026 at 20:57, 1 hour 48 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 05/04/2026 at 20:06, 2 hours 39 minutes ago Avril 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 05/04/2026 at 19:05, 3 hours 40 minutes ago CP -Mise en œuvre d’un contrat de liquidité avec INVEST SECURITIES
Published on 05/04/2026 at 18:19, 4 hours 26 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
